Cargando…
Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long‐term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitis
BACKGROUND: Allergen immunotherapy (AIT) is an approved treatment for seasonal respiratory allergic diseases. A depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy (SCIT) has been demonstrated to be efficacious and safe in patients allergic to birch pollen and its ho...
Autores principales: | Novak, Natalija, Worm, Margitta, Staubach, Petra, Jutel, Marek, Sager, Angelika, Pfaar, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533217/ https://www.ncbi.nlm.nih.gov/pubmed/36225264 http://dx.doi.org/10.1002/clt2.12185 |
Ejemplares similares
-
A high‐dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio
por: Pfaar, Oliver, et al.
Publicado: (2023) -
2 Dose Optimizing Study of a Depigmented Polymerized Allergen Extract of Birch Pollen by Means of Conjunctival Provocation Test
por: Sager, Angelika, et al.
Publicado: (2012) -
10 Seasonal Versus Symptom-based Evaluation of a Depigmented Grass-Birch Allergoid
por: Pfaar, Oliver, et al.
Publicado: (2012) -
Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patients
por: Pfaar, Oliver, et al.
Publicado: (2015) -
Subcutaneous immunotherapy with depigmented-polymerized allergen extracts: a systematic review and meta-analysis
por: Mösges, Ralph, et al.
Publicado: (2019)